AbbVie Inc. stock underperforms Friday when compared to competitors
The stock's fall snapped a two-day winning streak.
Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’
We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a ...
AbbVie Inc. (NYSE:ABBV) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the stock, Marketbeat.com ...
AbbVie's SWOT analysis: stock outlook strong despite humira loss
AbbVie Inc . (NYSE:ABBV), currently trading at $190.14, has demonstrated resilience and strategic foresight as it navigates the loss of exclusivity for its blockbuster drug Humira. The ...
Yahoo Finance3d
AbbVie Inc.'s (NYSE:ABBV) high institutional ownership speaks for itself as stock continues to impress, up 9.4% over last week
Hedge funds don't have many shares in AbbVie. Our data shows that The Vanguard Group, Inc. is the largest shareholder with 9.7% of shares outstanding. With 7.7% and 4.9% of the shares outstanding ...
Opinion
Hosted on MSN3dOpinion
Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie
Today's Research Daily features a real-time scorecard of the ongoing Q4 earnings season, in addition to the usual updated analyst reports on 16 major stocks, including Walmart Inc. (WMT), Visa Inc. (V ...
Nasdaq3d
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.